BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $518,000 | -61.2% | 4,839 | -62.8% | 0.02% | -57.1% |
| Q3 2021 | $1,336,000 | +18.3% | 12,994 | +1.2% | 0.04% | +55.6% |
| Q2 2021 | $1,129,000 | -20.1% | 12,836 | -11.7% | 0.03% | -20.6% |
| Q1 2021 | $1,413,000 | -15.6% | 14,529 | -2.7% | 0.03% | -5.6% |
| Q4 2020 | $1,674,000 | +265.5% | 14,925 | +160.7% | 0.04% | +260.0% |
| Q1 2019 | $458,000 | +48.2% | 5,725 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $309,000 | -30.9% | 5,725 | 0.0% | 0.01% | -20.0% |
| Q3 2018 | $447,000 | -42.7% | 5,725 | -53.4% | 0.01% | -44.4% |
| Q2 2018 | $780,000 | -30.8% | 12,285 | 0.0% | 0.02% | -33.3% |
| Q1 2018 | $1,127,000 | +79.5% | 12,285 | +47.5% | 0.03% | +92.9% |
| Q4 2017 | $628,000 | +8.3% | 8,330 | 0.0% | 0.01% | +7.7% |
| Q3 2017 | $580,000 | +37.4% | 8,330 | 0.0% | 0.01% | +44.4% |
| Q2 2017 | $422,000 | – | 8,330 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |